- Pharmaceutical Sciences Associate Professor Grant D. Trobridge and Pharmaceutical Sciences Research Technologist II Elizabeth Everson published, “Retroviral vector interactions with hematopoietic cells,” in Current Opinion in Virology, available online prior to print. Read article
- Elizabeth Everson, Pharmaceutical Sciences Research Technologist II David Leap, Pharmaceutical Sciences Research Technologist Jonah Hocum, Grant Trobridge, and one co-author published, “A comparison of foamy and lentiviral vector genotoxicity in SCID-repopulating cells shows foamy vectors are less prone to clonal dominance,” in the August 2016 issue of Molecular Therapy - Methods & Clinical Development, the peer-reviewed, open-access journal of the American Society of Gene & Cell Therapy. Read abstract
- Pharmaceutical Sciences Clinical Assistant Professor Ayesha Ahmed published, “Clinical pharmacology and toxicology of the current and new potential therapeutic agents for the treatment of iron overload,” in Research & Reviews: Journal of Pharmacology and Toxicological Studies, a peer-reviewed, open-access resource from the Research and Reviews International Journals. Read abstract
- Pharmacotherapy Professor and Chair John R. White, Jr., co-authored with one other, “Advances in basal insulin therapy,” published in the Journal of Pharmacy Technology in September 2016. Read abstract
- Pharmaceutical Sciences Research Associate Nahid Akhtar, Pharmaceutical Sciences Research Associate Anil Singh and Pharmaceutical Sciences Associate Professor Salah-Uddin Ahmed published, “MicroRNA-17 Suppresses TNF-α Signaling by Interfering with TRAF2 and cIAP2 Association in Rheumatoid Arthritis Synovial Fibroblasts,” in The Journal of Immunology, a peer-reviewed publication of the American Association of Immunologists, in September 2016. Read abstract
- Pharmacotherapy Clinical Associate Professor Lisa J. Woodard with four co-authors published, “An elective course to train student pharmacists to deliver a community-based group diabetes prevention program,” in the American Journal of Pharmaceutical Education. Read article
- Pharmacotherapy Clinical Professor and Vice Dean for External Relations Linda Garrelts Maclean co-presented with one other, “The key to high-performing teams,” at the International Pharmaceutical Federation (FIP) World Congress in Buenos Aires, Argentina, on August 29, 2016.
- Pharmaceutical Sciences Professor and Associate Dean for Graduate Education Kathryn E. Meier was selected to serve as the next editor of the journal Molecular Pharmacology, beginning in January 2017. Read full announcement
- Doctor of Pharmacy Preceptor Michael Varga received the 2016 WSU College of Pharmacy Preceptor of the Year award.
- Pharmacotherapy Clinical Assistant Professor Julie Akers received the 2016 David Almquist Award from the Washington State Pharmacy Association award. Read announcement
- Pharmacotherapy Emeritus Professor R. Keith Campbell received the 2016 Bill Mueller Outstanding Mentor Award from the Washington State Pharmacy Association. Read announcement
- Salah-Uddin Ahmed and one other received an administrative supplement in the amount of $82,371 over two years from the National Institutes of Health for the supplement R01 project, “RANTES/CCL5 mediated tissue remodeling in RA,” in order to promote diversity in health-related research.
- Allen I. White Distinguished Professor and Experimental and Systems Pharmacology Chair K. Michael Gibson received $134,937 over one year from the National Institutes of Health for the project, “Phase II Trial of SGS-742.”
Doctor of Philosophy (Ph.D.) students
- Aimee Sutliff, pharmaceutical sciences (Lazarus lab), presented, “MicroRNA regulation of the UGT2 sub-family of detoxifying enzymes,” as part of the Graduate Research Seminar Series on September 30, 2016.
- Victor Bii, pharmaceutical sciences (Trobridge lab), presented, “Gammaretroviral and lentiviral vector-based insertional mutagenesis screens identify genes that influence androgen-independent prostate cancer progression,” as part of the Graduate Research Seminar Series on September 23, 2016.
- Amity Platt, pharmaceutical sciences (Lazarus lab), presented, “Impact of nonsynonymous polymorphisms on in-vitro metabolism of exemestane by hepatic CYP450s,” as part of the Graduate Research Seminar Series on September 16, 2016.
- Shaman Luo, pharmaceutical sciences (Lazarus lab), presented, “Role of the UGT2B17 deletion in exemestane pharmacogenetics,” as part of the Graduate Research Seminar Series on September 9, 2016.
- Solomon Agere, pharmaceutical sciences (Ahmed lab), and faculty mentor Salah-Uddin Ahmed received an administrative supplement in the amount of $82,371 over two years from the National Institutes of Health for the supplement R01 project, “RANTES/CCL5 mediated tissue remodeling in RA.”